DJ AbbVie Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. $(ABBV)$ slid 1.23% to $190.60 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.95% to 6,025.99 and Dow Jones Industrial Average falling 0.99% to 44,303.40.
The stock's fall snapped a two-day winning streak.
AbbVie Inc. closed 8.06% short of its 52-week high of $207.32, which the company achieved on October 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.25% to $153.12, Pfizer Inc. $(PFE)$ fell 0.35% to $25.74, and Amgen Inc. $(AMGN)$ fell 1.42% to $293.54.
Data source: Dow Jones Market Data, FactSet. Data compiled February 7, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 07, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。